Published Date: 13 Dec 2023
One step closer to understanding why some patients experience a type of lymphoma that shifts from indolent to aggressive, and specifically toward determining which patients are most vulnerable to this transition, has been made by researchers.
Read Full News1.
Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers
2.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
3.
Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer
4.
Guideline on management of early-stage non-small cell lung cancer released
5.
New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
3.
Hemophilia: Pathophysiology, Genetics, and Treatment Advances
4.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
5.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
2.
Navigating the Complexities of Ph Negative ALL - Part V
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation